– Record date for each Special Meeting of Stockholders is February 5, 2021 – – Upon merger closing, combined company...
DUBLIN, Ireland, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an...
Results reported of the single ascending dose study in healthy volunteers Enrollment completed of the multiple ascending dose study in...
-- Key additions deepen drug development expertise and position the Company to advance pipeline --VANCOUVER, British Columbia, Feb. 10, 2021...
MENLO PARK, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (the “Company”), a leading...
Pittsburgh, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that treat neurodegenerative...
Webcasted Presentation to Be Held Tuesday, February 16, 2021 at 3:30PM (EST)CINCINNATI, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Protech Home...
2021 BIO CEO & Investor Digital Conference15th International Conference on Alzheimer’s and Parkinson’s Diseases AD/PD 2021 H.C. Wainwright Global Life...
CAMBRIDGE, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...
Panbela is studying patients with pancreatic cancer testing investigative agent SBP-101 when used in combination with standard of care agents...
NEWARK, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing...
MENLO PARK, Calif. and BOSTON, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a biotechnology company...
Vancouver, Canada, Feb. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq: NVCN / TSX: NVCN)...
COPENHAGEN, Denmark, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech, a clinical-stage biotechnology company specializing in the development of AI-driven...
TORONTO and KINGSTON, Jamaica, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc., through its wholly-owned subsidiary Psyence Therapeutics Corp....
SAN DIEGO, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record...
Agreement will expand clinical development for a potent and selective small molecule targeting TBL1, a downstream target in the Wnt/β-catenin...
Advancement Expected to Further Accelerate Development of mRNA Vaccines and TherapeuticsSAN DIEGO, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences,...
FOSTER CITY, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage...
Provides Expanded Protection to Seminal Patents Related to DNAbilizeHOUSTON, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a...